[
American Diabetes Association. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes-2018. Diabetes Care 41, 28–37, 2018.10.2337/dc18-S00329222374
]Search in Google Scholar
[
American Diabetes Association. Cardiovascular disease and risk management: standards of medical care in diabetes-2019. Diabetes Care 42, 103–123, 2019.10.2337/dc19-S01030559236
]Search in Google Scholar
[
Arora M, Koley S, Gupta S, Sandhu JS. A study on lipid profile and body fat in patients with diabetes mellitus. Anthropologist 9, 295–298, 2007.10.1080/09720073.2007.11891015
]Search in Google Scholar
[
Bilous II, Korda MM, Krynytska IY, Kamyshnyi AM. Nerve impulse transmission pathway-focused genes expression analysis in patients with primary hypothyroidism and autoimmune thyroiditis. Endocr Regul 54, 109–118, 2020a.10.2478/enr-2020-001332597152
]Search in Google Scholar
[
Bilous I, Pavlovych L, Krynytska I, Marushchak M, Kamyshnyi A. Apoptosis and cell cycle pathway-focused genes expression analysis in patients with different forms of thyroid pathology. OAMJMS 8, 784–792, 2020b.10.3889/oamjms.2020.4760
]Search in Google Scholar
[
Bluher M, Stumvoll M. Diabetes and Obesity. In: Bonora E., DeFronzo R (eds.). Diabetes Complications, Comorbidities and Related Disorders. Endocrinology. Springer Cham, 2020.10.1007/978-3-030-36694-0_1
]Search in Google Scholar
[
Chernatska O, Demikhov N, Rudenko T, et al. Assesment of the lipid profile correction in patients with arterial hypertension and type 2 diabetes mellitus. Azerbaijan Med J 1, 95–99, 2019.
]Search in Google Scholar
[
Chhatriwala MN, Patel MP, Patel DSB, Shah HN. Relationship between dyslipidemia and glycemic status in T type-2 Diabetes Mellitus. Nat J Lab Med 8, 1–4, 2019.10.7860/NJLM/2019/42887:2371
]Search in Google Scholar
[
Chitra R, Hinge, Sachin B. Ingle, Baban D. Adgaonkar. Body mass index, blood pressure and lipid profile in type 2 diabetes - review. Int J Cur Res Rev 10, 1–9, 2018.10.31782/IJCRR.2018.10101
]Search in Google Scholar
[
Christiansen E, Urban C, Merten N, Liebscher K, Karlsen KK, Hamacher A, Spinrath A, Bond AD, Drewke C, Ullrich S, Kassack MU, Kostenis E, Ulven T. Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA(1)/GPR40), a potential target for the treatment of type II diabetes. J Med Chem 51, 7061–7064, 2008.10.1021/jm801017818947221
]Search in Google Scholar
[
Conwell DL, Lee LS, Yadav D, Longnecker DS, Miller FH, Mortele KJ, Levy MJ, Kwon R, Lieb JG, Stevens T, Toskes PP, Gardner TB, Gelrud A, Wu BU, Forsmark CE, Vege SS. American pancreatic association practice guidelines in chronic pancreatitis: evidence-based report on diagnostic guidelines. Pancreas 43, 1143–1162, 2014.10.1097/MPA.0000000000000237543497825333398
]Search in Google Scholar
[
Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, Huikuri HV, Johansson I, Jüni P, Lettino M, Marx N, Mellbin LG, Ostgren CJ, Rocca B, Roffi M, Sattar N, Seferovic PM, Sousa-Uva M, Valensi P, Wheeler DC; ESC Scientific Document Group. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 41, 255–323, 2020.
]Search in Google Scholar
[
Degen AS, Krynytska IY, Kamyshnyi AM. Changes in the transcriptional activity of the entero-insular axis genes in streptozotocin-induced diabetes and after the administration of TNF-α non-selective blockers. Endocr Regul 54, 160–171, 2020.10.2478/enr-2020-001932857721
]Search in Google Scholar
[
Demikhova N, Cherkashyna L, Chernatska O. The relationship between lipid metabolism and albuminuria level with single nucleotide polymorphism -204a>c [rs 3808607] CYP7A1 gene in patients with 2 type diabetes mellitus and diabetic nephropathy. Rom J Diabetes Nutr Metab Dis 26, 253–261, 2019.10.2478/rjdnmd-2019-0026
]Search in Google Scholar
[
Gaman MA, Dobrica EC, Cozma MA, Antonie NI, Stanescu AMA, Gaman AM, Diaconu CC. Crosstalk of magnesium and serum lipids in dyslipidemia and associated disorders: a systematic review. Nutrients 13, 1411, 2021.10.3390/nu13051411814602333922341
]Search in Google Scholar
[
Gao D, Nong S, Huang X, Lu Y, Zhao H, Lin Y, Man Y, Wang S, Yang J, Li J. The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways. J Biol Chem 285, 29965–29973, 2010.10.1074/jbc.M110.128694294326120647313
]Search in Google Scholar
[
Hamilton SJ, Watts GF. Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment. Rev Diabet Stud 10, 133–156, 2013.10.1900/RDS.2013.10.133406310024380089
]Search in Google Scholar
[
Hevko U, Kozak K, Krynytska I, Marushchak M. Diagnostic value of a complete blood count in type 2 diabetes mellitus and comorbidities. Arch Balk Med Union 55, 601–607, 2020.10.31688/ABMU.2020.55.4.06
]Search in Google Scholar
[
Hosseini S, Alipour M, Zakerkish M, Cheraghian B, Ghandil P. Effects of epigallocatechin gallate on total antioxidant capacity, biomarkers of systemic low-grade inflammation and metabolic risk factors in patients with type 2 diabetes mellitus: the role of FTO-rs9939609 polymorphism. Arch Med Sci 17, 1722–1729, 2020.10.5114/aoms.2020.95903864149134900054
]Search in Google Scholar
[
International Diabetes Federation. IDF Diabetes Atlas. 9th edition Brussels (BEL). IDF. 2019. https://www.diabetesatlas.org/en/
]Search in Google Scholar
[
Jialal I, Singh G. Management of diabetic dyslipidemia: An update. World J Diabet 10, 280–290, 2019.10.4239/wjd.v10.i5.280652275631139315
]Search in Google Scholar
[
Khrystych TM. Blood lipids in chronic pancreatitis combined with coronary heart disease: limitations of correction. Gastroenterology 3, 56–63, 2014.
]Search in Google Scholar
[
Kutoh E, Hayashi J, Kuto AN. Efficacy and safety of dulaglutide in patients with absolute insulin deficiency. Endocr Regul 53, 187–190, 2019.10.2478/enr-2019-001931517629
]Search in Google Scholar
[
Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabet 6, 1246–1258, 2015.10.4239/wjd.v6.i13.1246460017626468341
]Search in Google Scholar
[
Maev IV, Kucheryavyy YuA. Autoimmune pancreatitis: current state of the art. Therap Arch 2, 56–61, 2012.
]Search in Google Scholar
[
Marushchak M, Krynytska І, Klishch I, Gabor G, Antonyshyn I. The relationship between experimental alimentary obesity and hard tooth tissues mineralization. Jordan Med J 51, 25–33, 2017.10.12816/0039753
]Search in Google Scholar
[
Marushchak M, Maksiv K, Krynytska I, Stechyshyn I. Glutathione antioxidant system of lymphocytes in the blood of patients in a setting of concomitant chronic obstructive pulmonary disease and arterial hypertension. Polski Merkur Lek 47(281), 177–182, 2019.
]Search in Google Scholar
[
Marushchak M, Krynytska I. Insulin receptor substrate 1 gene and glucose metabolism characteristics in type 2 diabetes mellitus with comorbidities. Ethiop J Health Sci 31, 1001, 2021.
]Search in Google Scholar
[
Mooradian AD, Albert SG, Haas MJ. Low serum high-density lipoprotein cholesterol in obese subjects with normal serum triglycerides: the role of insulin resistance and inflammatory cytokines. Diabetes Obes Metab 9, 441–443, 2007.10.1111/j.1463-1326.2006.00636.x
]Search in Google Scholar
[
Nowakowska M, Zghebi SS, Ashcroft DM, Buchan I, Chew-Graham C, Holt T, Mallen C, Van Marwijk H, Peek N, Perera-Salazar R, Reeves D, Rutter MK, Weng SF, Qureshi N, Mamas MA, Kontopantelis E. The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort. BMC Med 17, 145, 2019.10.1186/s12916-019-1373-y
]Search in Google Scholar
[
Pavlyshyn H, Kozak K, Marushchak M. Association between night eating syndrome in overweight and obese children 10-17 years of age and dyslipidemia. Romanian Journal of Diabetes, Nutrition and Metabolic Diseases 28, 69–76, 2021.
]Search in Google Scholar
[
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al. European Guidelines on cardiovascular disease prevention in clinical practice. Kardiol Pol 74, 821–936, 2016.10.5603/KP.2016.0120
]Search in Google Scholar
[
Posokhova K, Stechyshyn I, Krynytska I, Marushchak M, Birchenko I, Klishch I. Comparative study of the effect of various forms of quercetin on experimental diabetes. Romanian Journal of Diabetes, Nutrition and Metabolic Diseases 25, 383–388, 2018.10.2478/rjdnmd-2018-0046
]Search in Google Scholar
[
Rhee EJ, Kim HC, Kim JH, Lee EY, Kim BJ, Kim EM, et al. Guidelines for the management of dyslipidemia. Korean J Intern Med 34, 723–771, 2019.10.3904/kjim.2019.188
]Search in Google Scholar
[
Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375, 2267–2277, 2010.10.1016/S0140-6736(10)60408-4
]Search in Google Scholar
[
Sapkota LB, Thapa S. Pattern of dyslipidemia in type 2 diabetic patients attending Tertiary Care Centre of Nepal. EC Endocrinology and Metabolic Research 4, 15–22, 2019.
]Search in Google Scholar
[
Shankarprasad DS, Gundalli S, Mahantesh B, Kashinakunti SV, Sunitha P. Lipid profile in Diabetes Mellitus. Ind J Pathol Oncol 290–294, 2015.10.5958/2394-6792.2015.00030.7
]Search in Google Scholar
[
Shatynska O, Tokarskyy O, Lykhatskyi P, Yaremchuk O, Bandas I, Mashtalir A. Dietary supplementation with magnesium citrate may improve pancreatic metabolic indices in an alloxan-induced diabetes rat model. Potr. S. J. F. Sci 14, 836–846, 2020.10.5219/1375
]Search in Google Scholar
[
Shemesh E, Zafrir B. Hypertriglyceridemia-related pancreatitis in patients with type 2 diabetes: links and risks. Diabetes Metab Syndr Obes 12, 2041–2052, 2019.10.2147/DMSO.S188856678996931632114
]Search in Google Scholar
[
Shen GX. Lipid disorders in diabetes mellitus and current management. Curr Pharm Anal 3, 17–24, 2007.10.2174/157341207779802386
]Search in Google Scholar
[
Silitonga HA, Siahaan JM, Anto EJ. Correlation between obesity and lipid profile in type 2 diabetes mellitus patients at the Endocrine and Metabolic Polyclinic in General Hospital Pirngadi Medan. Maced J Med Sci 7, 1309–1313, 2019.10.3889/oamjms.2019.312651434631110575
]Search in Google Scholar
[
Sirchak ES, Opalenyk SM. Violation of lipid profile in patients with chronic pancreatitis. Clin Exp Med 1, 59–63, 2017.
]Search in Google Scholar
[
Sydorchuk L, Dzhuryak V, Sydorchuk A, Levytska S, Petrynych V, Knut R, Kshanovska A, Iftoda O, Tkachuk O, Kyfiak P, Popovich A, Khomko O, Sydorchuk R. The cytochrome 11B2 aldosterone synthase gene rs1799998 single nucleotide polymorphism determines elevated aldosterone, higher blood pressure, and reduced glomerular filtration, especially in diabetic female patients. Endocr Regul 54, 217–226, 2020.10.2478/enr-2020-002432857720
]Search in Google Scholar
[
Trovati M, Cavalot F. Optimization of hypolipidemic and antiplatelet treatment in the diabetic patients with renal disease. J Am Soc Nephrol 15, 12–20, 2004.10.1097/01.ASN.0000093238.09114.40
]Search in Google Scholar
[
Ugwuja E, Ogbonna N, Nwibo A, Onimawo I. Overweight and obesity, lipid profile and atherogenic indices among civil servants in Abakaliki, South Eastern Nigeria. Ann Med Health Sci Res 3, 13–18, 2013.10.4103/2141-9248.109462363421323634323
]Search in Google Scholar
[
Verges B. Pathophysiology of diabetic dyslipidaemia: Where are we? Diabetologia 58, 886–899, 2015.10.1007/s00125-015-3525-8439216425725623
]Search in Google Scholar
[
Young EE, Okafor CN, Okwara CC. Diabetes mellitus, associated comorbidities and complications - A review. Journal of Medicine and Medical Sciences 7, 47–55, 2016.
]Search in Google Scholar
[
Zeqollari A, Spahiu K, Vyshka G, Cakerri L. Lipid profile in diabetes mellitus type 2 patients in Albania and the correlation with BMI, hypertension, and hepatosteatosis. J Family Med Community Health 1, 1018, 2014.
]Search in Google Scholar
[
Zhang Y, Yang S, Zhang M, Wang Z, He X, Hou Y, Bai G. Glycyrrhetinic acid improves insulin-response pathway by regulating the balance between the Ras/MAPK and PI3K/Akt pathways. Nutrients 11, 604, 2019.10.3390/nu11030604647047330871060
]Search in Google Scholar
[
Zhuravleva LV, Shekhovtsova YA. Comorbidity of chronic pancreatitis and diabetes type 2: possible options of pharmacoteraphy. Practical Likar 5, 21–25, 2016.
]Search in Google Scholar
